A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
Recruiting · NCT07089992 · Registry updated 2026-07-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Pembrolizumab in People With Ultra-Rare Sarcomas | Neoplasms by Histologic Type, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, liposarcoma, neoplasm, neoplasm with perivascular epithelioid cell differentiation, sarcoma | Recruiting | Phase 2 | 2026-07-28 | NCT07089992 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 753 |
| Merck Sharp & Dohme LLC | 650 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Memorial Sloan Kettering at Basking Ridge (All Protocol Activities) | Basking Ridge | United States | 14 |
| Memorial Sloan Kettering at Westchester (Limited Protocol Activities) | Harrison | United States | 12 |
| Memorial Sloan Kettering Bergen (Limited Protocol Activities) | Montvale | United States | 184 |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York | United States | 230 |
| Memorial Sloan Kettering Cancer Center Suffolk- Commack (Limited Protocol Activities) | Commack | United States | 4 |
| Memorial Sloan Kettering Monmouth (Limited Protocol Activities) | Middletown | United States | 186 |
| Memorial Sloan Kettering Nassau (All Protocol Activities) | Uniondale | United States | 53 |